Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the... SOUTH SAN FRANCISCO, Calif., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Surrozen ...

Fintel reports that on January 3, 2025, Guggenheim upgraded their outlook for Surrozen (NasdaqCM:SRZN) from Neutral to Buy. Analyst Price Forecast Suggests 136.21% Upside As of December 23 ...

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at ...

Check the time stamp on this data. Updated AI-Generated Signals for Surrozen Inc. (SRZN) available here: SRZN. Type a few ...

Guggenheim analyst Yatin Suneja upgraded Surrozen (SRZN) to Buy from Neutral with a $45 price target Discover the latest stocks recommended by top Wall Street analysts, all in one place with ...

Why Nuvve Holding Shares Are Trading Lower By Around 30%? Here Are Other Stocks Moving In Monday's Mid-Day Session Shares of Nuvve Holding Corp. (NASDAQ: NVVE) fell sharply during Monday’s ...

As previously reported, Guggenheim upgraded Surrozen (SRZN) to Buy from Neutral with a $45 price target Recent Phase 1b data for SZN-043, the company’s lead asset for liver disease, was ...

Surrozen, Inc. is a clinical stage biotechnology company. It engages in the business of discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of ...

SOUTH SAN FRANCISCO, Calif., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Surrozen, Inc. (“Surrozen” or the “Company”) (Nasdaq: SRZN), a company pioneering targeted ...

As of December 23, 2024, the average one-year price target for Surrozen is $33.66/share. The forecasts range from a low of $33.33 to a high of $34.65. The average price target represents an ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...